Supported by

TAVI (Transcatheter aortic valve implantation)

Find all the latest content on TAVI published on this website.

TAVI, now an established, valid treatment for patients presenting with symptomatic severe aortic stenosis, has proven to be superior to medical treatment for inoperable patients whilst being a valid alternative to surgery in select, high-risk patients. This topic covers the newest devices and emerging data in TAVI as well as information on tools, devices and techniques such as vascular access; the role of adjunctive pharmacotherapy; imaging techniques such as echocardiography, understanding bleeding risks or patient selection. Use the filters below to access PCRonline resources.

Anatomy of the aortic valvar complex

View a detailed and comprehensive description of the anatomy of the aortic valvar complex as it pertains to TAVI.

View illustrated aortic valvar complex

Filtered By
TAVI

1332 results

TAVI session from PCR London Valves 2025 : Abbott

26 Nov 2025

Watch these recordings from PCR London Valves 2025 on TAVI.

TAVI sessions from PCR London Valves: Abbott

Coronary Interventions: EuroPCR 2025 highlights

22 May 2025 – From EuroPCR 2025

At EuroPCR 2025, Rasha Al-Lamee, Nieves Gonzalo, and Thomas Cuisset highlighted key advances in coronary interventions, with a strong emphasis on managing complex cases—particularly calcified lesions.

Throughout the Course, LIVE cases and expert hotlines showcased dedicated devices and evolving strategies designed specifically for these challenging lesions. Advanced...

Coronary: EuroPCR 2025 highlights

Structural and Valvular Interventions: EuroPCR 2025 highlights

22 May 2025 – From EuroPCR 2025

Christopher Cook, Nicolas Dumonteil, and Bernard Prendergast share their top EuroPCR 2025 highlights in structural heart interventions. Challenging cases like re-do TAVI, coronary re-access difficulties, and leaflet modification took center stage in case-based and LIVE sessions. Cutting-edge research was featured too, including a meta-analysis combining the...

Structural: EuroPCR 2025 highlights

TAVI and the left ventricular myocardium

23 May 2025 – From EuroPCR 2025

Understand the intricate relationship between TAVI and left ventricular myocardium through discussions on cardiac damage stages, functional remodeling, and pharmacological interventions post-TAVR. This session also reviews prophylactic ECMO support in high-risk patients, offering a comprehensive perspective on optimizing TAVI outcomes.

TAVI and the left ventricular myocardium

Permanent pacing after TAVI

23 May 2025 – From EuroPCR 2025

Explore predictors and mechanisms leading to permanent pacemaker implantation after TAVI. This session reviews electrophysiological intervals, atrial pacing markers, anatomical risk factors, and outcomes associated with new generation transcatheter heart valves.

Permanent pacing after TAVI

High-risk PCI in TAVI procedures

23 May 2025 – From EuroPCR 2025

This session highlights high-risk PCI in the context of TAVI procedures, including hybrid approaches for aortic stenosis with coronary disease, valve-in-valve scenarios, and unique anatomical challenges such as total situs inversus, emphasizing comprehensive patient management.

High-risk PCI in TAVI procedures

Navigating complexity: TAVI in challenging anatomies

22 May 2025 – From EuroPCR 2025

Navigate the complexities of TAVI in challenging anatomies. This session reviews anatomical variations such as horizontal aorta, iliofemoral tortuosity, low coronary ostia, bicuspid valves, and annular eccentricity, alongside preprocedural imaging and risk stratification. It further evaluates device selection and procedural adaptations essential for successful TAVI in...

Navigating complexity: TAVI in challenging anatomies

TAVI coronary access

22 May 2025 – From EuroPCR 2025

Gain expertise in managing coronary access challenges in TAVI patients. This session discusses when and how to treat coronary lesions in TAVI candidates, strategies to facilitate coronary approach post-TAVI, and long-term outcomes with practical tips through illustrative cases including primary PCI after CoreValve implantation and valve-in-valve...

TAVI coronary access

Management of challenging TAVI device delivery

22 May 2025 – From EuroPCR 2025

Explore innovative solutions for managing challenging TAVI device delivery. This session presents cases involving kinked and stuck Navitor valves, the use of snare devices for retrieval, balloon-expandable TAVI in severe bicuspid aortic stenosis, and alternative access routes such as transaortic access after failed transfemoral valve-in-valve procedures.

Management of challenging TAVI device delivery

From evidence to practice: solving complex cases with EuroIntervention

22 May 2025 – From EuroPCR 2025

Translate evidence into clinical practice with this session focusing on complex case analyses supported by EuroIntervention resources. Experience detailed presentations of challenging PCI, intracoronary imaging, coronary physiology, and TAVI cases, each followed by evidence-based solutions provided through EuroIntervention. Enhance your decision-making skills by integrating guidelines and...

From evidence to practice: solving complex cases with EuroIntervention

TAVI and coronary artery disease

22 May 2025 – From EuroPCR 2025

Examine the evolving role of coronary artery disease assessment in TAVI patients. This session compares coronary tomography and angiography for pre-TAVI evaluation, reviews safety and effectiveness of CT angiography-based strategies, and introduces the UNICORN procedure for managing high coronary obstruction risk in complex TAVI scenarios including...

TAVI and coronary artery disease

TAVI outcomes

22 May 2025 – From EuroPCR 2025

Examine contemporary outcomes of transcatheter aortic valve implantation (TAVI) across diverse patient populations and device generations. This session presents data on severe aortic stenosis stratified by resting gradient, comparisons between bicuspid and tricuspid valve stenosis, and clinical results of intra-annular versus supra-annular devices, including two-year outcomes...

TAVI outcomes

All you need to know on aorto iliac disease during TAVI: from access to complications management

22 May 2025 – From EuroPCR 2025

Gain expertise in managing aorto-iliac disease during TAVI procedures, from access planning to complication management. This session covers key imaging techniques, decision-making regarding stenting and lesion modification, approaches to access-related complications, and criteria for involving vascular surgeons, ensuring procedural safety and success.

All you need to know on aorto iliac disease during TAVI: from access to complications management

TAVI in bicuspid aortic valve disease

22 May 2025 – From EuroPCR 2025

Explore the unique challenges of TAVI in bicuspid aortic valve disease with a focus on long-term outcomes, residual gradients, prosthesis-patient mismatch, and anatomical subtype comparisons. This session draws on international registry data to inform clinical decision-making and optimize procedural strategies in this complex patient population.

TAVI in bicuspid aortic valve disease

TAVI in difficult scenarios: bicuspid anatomy and pure aortic regurgitation

22 May 2025 – From EuroPCR 2025

Address challenging TAVI scenarios involving bicuspid anatomy and pure aortic regurgitation with insights from international experiences. This session compares treatment options in China and Germany, explores anatomical and disease differences, and reviews various TAVI devices through detailed case presentations and expert commentary.

TAVI in difficult scenarios: bicuspid anatomy and pure aortic regurgitation

Outcome prediction using artificial intelligence and meta-analysis

22 May 2025 – From EuroPCR 2025

This session presents outcome prediction advancements through artificial intelligence and meta-analysis in cardiology. Topics include AI-guided aortic stenosis risk stratification, predictors of periprocedural stroke after TAVI, patient-specific computer simulations for bicuspid TAVI, and enhancements in large language model accuracy using Heart Team simulation.

Outcome prediction using artificial intelligence and meta-analysis

Patients with degenerated aortic bioprothesis - Every case is different

22 May 2025 – From EuroPCR 2025

Delve into the nuanced management of patients with degenerated aortic bioprostheses, emphasizing that no two cases are alike. This session provides expert insights into selecting optimal valve-in-valve TAVI approaches tailored to individual anatomy and clinical context. Learn practical strategies to overcome complex challenges such as coronary...

Patients with degenerated aortic bioprothesis - Every case is different

Managing TAVI-embolisation device

22 May 2025 – From EuroPCR 2025

Focus on managing TAVI device embolization in this specialized session. Discuss detailed techniques such as TAVI-in-TAVI procedures, addressing valve dysfunction, and innovative balloon-assisted retrieval methods for migrated transcatheter heart valves, emphasizing procedural nuances and bailout strategies.

Managing TAVI-embolisation device

TAVI new devices

22 May 2025 – From EuroPCR 2025

Explore the latest innovations in transcatheter aortic valve implantation (TAVI) devices with a focus on coronary protection strategies, cerebral embolic protection integration, management of ventricular migration, and overcoming anatomical challenges such as bicuspid and rheumatic valve disease using novel platforms.

TAVI new devices

TAVI in bicuspid: all you need to know

22 May 2025 – From EuroPCR 2025

Understand the unique anatomical and clinical challenges of transcatheter aortic valve implantation (TAVI) in bicuspid aortic valves. This session covers bicuspid valve epidemiology, indications for surgery and TAVI, and detailed discussion on sizing and deployment fundamentals specific to bicuspid anatomy to optimize procedural success.

TAVI in bicuspid: all you need to know